The French speciality pharmaceutical company, Juvisé Prescribed drugs is pleased to announce the profitable completion of a transaction with AstraZeneca, regarding the acquisition of the business rights of Arimidex® ( anastrozole ) and Casodex® ( bicalutamide ) in quite a lot of European, African and other nations. Arimidex® (anastrozole) is an aromatase inhibitor, indicated primarily for the adjuvant therapy of postmenopausal girls with hormone receptor-constructive early breast most cancers, the first-line therapy of postmenopausal women with hormone receptor-optimistic or hormone receptor-unknown domestically superior or metastatic breast cancer and the treatment of advanced breast most cancers in postmenopausal girls with illness development, following tamoxifen remedy.
Arimidex, additionally called anastrozole, stops the manufacturing of estrogen in postmenopausal girls so it does not stimulate the production of breast cancer cells, while Casodex or bicalutamide equally prevents androgens in males affected by prostate most cancers.
Within casodex pills -blind comparison of flutamide versus bicalutamide, each in combination with an LHRH-A 22 , cardiovascular hostile occasions occurred in a similar proportion of patients in each groups when all antagonistic occasions have been considered, regardless of causality (Table 2 ⇓ ).
This is applicable to all medication (prescription and non-prescription), pure health merchandise, biologics comparable to blood products or vaccines, radiopharmaceuticals, and disinfectants, and is not only for generic products. casodex active ingredient
why is casodex prescribed
Order Casodex Online No Prior Prescription - CLICK HERE
generic medication for bicalutamide
casodex no prescription
Bicalutamide tablets are additionally available without a brand identify, ie as the generic medicine.
Sufferers with ER(+) AR(+) breast most cancers should have had at the least 1 prior line of endocrine remedy to be eligible for the section I portion of the trial. LUPRON DEPOT‑PED® ( can you get bicalutamide over the counter for depot suspension) 7.5 mg, 11.25 mg, and 15 mg for 1‑month and eleven.25 mg and 30 mg for 3‑month administration are prescribed for the therapy of youngsters with central precocious puberty (CPP).